Key facts
- Formation Bio’s last known valuation is $1.7B.
- It has raised $618.8M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($159.5M) in Sep 2021.
- Notable investors include Andreessen Horowitz, Sequoia Capital, Spark Capital, SV Angel, Felicis — 26 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Formation Bio
Funding rounds
1 roundsAbout Formation Bio
Developer of a biotech investment and development platform intended to accelerate drug development. The company's platform utilizes AI-driven technologies, customized workflow enhancements, strategic acquisition of clinical-stage assets, adaptable licensing structures, and integrated expert teams, enabling pharma partners and research institutions to advance treatments more efficiently while reducing cost, time, and development risk.
- Industry
- Drug Discovery
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2013
- Employees
- 180
- Website
- formation.bio/
- Ownership
- Privately Held (backing)
Formation Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Formation Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Formation Bio in its N-PORT filings yet. We sweep new filings monthly.